Victrex
Nicola Thompson (nee Ditchburn) has a strong background in intellectual property, with a focus on patents and trademarks. Nicola began their career as a Trainee Patent Attorney at Dyson in 1998 and worked there until 2003. After that, they joined Appleyard Lees as a Senior Associate and stayed there until 2011. During this time, they gained valuable experience in patent law. In 2011, Thompson joined Pilkington as a European Patent & Trade Mark Attorney and worked there until 2014. Nicola then moved to Victrex, where they held the position of Head of Intellectual Property from 2014 to 2022, and later transitioned into the role of Director of Intellectual Property. With their extensive experience in intellectual property law, Thompson is a valuable asset to any organization.
Nicola Thompson (nee Ditchburn) pursued their education in the field of Intellectual Property at The University of Manchester. However, the specific duration or completion of their degree is not mentioned.
This person is not in any teams
This person is not in any offices
Victrex
2 followers
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company's operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. The Company offers polyetheretherketone (PEEK) and polyaryletherketone (PAEK)-based polymer solutions. The Company's geographical locations include the United Kingdom; Europe, Middle East and Africa (EMEA); Americas, and Asia-Pacific. Its solutions are used in a range of applications, such as braking systems in automotive market, seal rings in energy market, mobile devices in electronics market and implanted devices in medical market. Its subsidiaries include Victrex Manufacturing Limited and Invibio Limited.